ANGLE plc

Status: Publicly traded

Direct answer

ANGLE plc is publicly traded on LSE under the ticker AGL.L.

ANGLE plc is a medical diagnostics firm that specializes in developing advanced products for cancer detection. Its flagship offering is the Parsortix cell separation system, engineered to isolate and collect circulating tumor cells (CTCs) from the bloodstream of patients with metastatic breast cancer. The company also provides the HyCEAD multiplex analysis system, which enables both routine and targeted analysis of...

Can you invest in ANGLE plc?

Yes. ANGLE plc is publicly traded on LSE under the ticker AGL.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for ANGLE plc

Detailed equity research is provided by MarketSnap.